Jacobs Levy Equity Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-12,256
Closed -$315K 1119
2020
Q2
$315K Hold
12,256
﹤0.01% 879
2020
Q1
$188K Sell
12,256
-206,159
-94% -$4.48M ﹤0.01% 896
2019
Q4
$7.49M Buy
218,415
+20,488
+10% +$246K 0.07% 300
2019
Q3
$1.48M Buy
197,927
+81,243
+70% +$779K 0.02% 563
2019
Q2
$1.51M Buy
116,684
+7,100
+6% +$91.1K 0.02% 568
2019
Q1
$1.33M Buy
109,584
+37,570
+52% +$480K 0.02% 600
2018
Q4
$820K Buy
72,014
+61,389
+578% +$991K 0.01% 641
2018
Q3
$231K Sell
10,625
-2,295
-18% -$48K ﹤0.01% 910
2018
Q2
$228K Buy
+12,920
New +$262K ﹤0.01% 933
2018
Q1
Sell
-16,770
Closed -$243K 1073
2017
Q4
$243K Buy
16,770
+5,100
+44% +$78.7K ﹤0.01% 870
2017
Q3
$184K Buy
+11,670
New +$171K ﹤0.01% 877
2016
Q2
Sell
-53,224
Closed -$1.48M 1242
2016
Q1
$1.48M Buy
+53,224
New +$1.77M 0.03% 482

Other funds holding ITCI